Drug news
NICE recommends Xarelto for DVT and PE
In final draft guidance, the National Institute for Health and Clinical Excellence (NICE) recommends the use of Xarelto (rivaroxaban) from Bayer HealthCare as an option for treating deep vein thrombosis (DVT) and preventing recurrent DVT and pulmonary embolism in adults diagnosed with acute DVT.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.